Thrombogenics Nv operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Thrombogenics Nv with three other
miscellaneous service companies in Europe:
Bioinvent International AB
sales of 71.28 million Swedish Kronor [US$8.20 million]
of which 100%
was Drug Development),
(6.78 million Euro [US$7.62 million]
based in Sweden
(74.92 million Swedish Kronor [US$8.62 million]
During the year ended December of 2016, sales at
Thrombogenics Nv were 7.10 million Euro (US$7.98 million).
decrease of 36.6%
versus 2015, when the company's sales were 11.20 million Euro.